WESPAC Advisors SoCal’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
SC
ONB
GIM
WESPAC Advisors SoCal's LLY Position: Q2 2026 in Review
WESPAC Advisors SoCal increased its Eli Lilly (LLY) stake by 27% in Q2 2026, buying an estimated $189K and bringing the position to 858 shares worth $1.03M. The position accounts for 0.18% of the portfolio, ranked #81.
WESPAC Advisors SoCal first reported a position in LLY in Q4 2015 and has held it in 15 quarters since. The position peaked at $14.8M in Q3 2024. 1,669 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- WESPAC Advisors SoCal held 858 shares of Eli Lilly worth $1.03M as of Q2 2026.
- WESPAC Advisors SoCal bought 185 Eli Lilly shares in Q2 2026, an estimated $189K.
- Eli Lilly made up 0.18% of WESPAC Advisors SoCal's portfolio in Q2 2026, its #81 holding.
- WESPAC Advisors SoCal first reported a position in Eli Lilly in Q4 2015 and has held it in 15 quarters since.
- WESPAC Advisors SoCal's Eli Lilly position peaked at $14.8M in Q3 2024.
- 1,669 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on WESPAC Advisors SoCal's 13F filing for Q2 2026, filed 16 Jul 2026.